First-Line Anti-TNFs Keep Rheumatoid Arthritis Manageable Long-Term

(MedPage Today) -- BARCELONA -- Rheumatoid arthritis (RA) patients were exceedingly unlikely to develop refractory disease when their first medical therapy was a tumor necrosis factor (TNF) inhibitor, a researcher reported here.
Among patients...